OneDigital Investment Advisors’s Iterum Therapeutics ITRM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-191,000
Closed -$128K 1555
2025
Q3
$128K Buy
191,000
+30,000
+19% +$23.5K ﹤0.01% 1450
2025
Q2
$160K Buy
161,000
+60,000
+59% +$62.6K ﹤0.01% 1398
2025
Q1
$124K Buy
+101,000
New +$150K ﹤0.01% 1354
2022
Q3
Sell
-1,104
Closed -$3K 779
2022
Q2
$3K Hold
1,104
﹤0.01% 707
2022
Q1
$6K Hold
1,104
﹤0.01% 751
2021
Q4
$6K Buy
+1,104
New +$8.53K ﹤0.01% 788

Other funds holding ITRM

OneDigital Investment Advisors's ITRM Position: Q4 2025 in Review

OneDigital Investment Advisors sold out of Iterum Therapeutics (ITRM) in Q4 2025, closing a stake of 191,000 shares — an estimated $128K sold.

OneDigital Investment Advisors first reported a position in ITRM in Q4 2021 and held it in 6 quarters. The position peaked at $160K in Q2 2025. 20 funds tracked by Wall St. Rank hold ITRM as of Q4 2025.

  • OneDigital Investment Advisors reported no remaining Iterum Therapeutics position as of Q4 2025 after selling out during the quarter.
  • OneDigital Investment Advisors sold 191,000 Iterum Therapeutics shares in Q4 2025, an estimated $128K.
  • OneDigital Investment Advisors first reported a position in Iterum Therapeutics in Q4 2021 and held it in 6 quarters.
  • OneDigital Investment Advisors's Iterum Therapeutics position peaked at $160K in Q2 2025.
  • 20 funds tracked by Wall St. Rank held Iterum Therapeutics as of Q4 2025.

Based on OneDigital Investment Advisors's 13F filing for Q4 2025, filed 13 Feb 2026.